annual EBITDA:
-$211.22M-$123.53M(-140.88%)Summary
- As of today (August 31, 2025), SMMT annual EBITDA is -$211.22 million, with the most recent change of -$123.53 million (-140.88%) on December 31, 2024.
- During the last 3 years, SMMT annual EBITDA has fallen by -$106.52 million (-101.74%).
- SMMT annual EBITDA is now -171201.70% below its all-time high of -$123.30 thousand, reached on January 31, 2004.
Performance
SMMT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$568.40M-$501.57M(-750.57%)Summary
- As of today (August 31, 2025), SMMT quarterly EBITDA is -$568.40 million, with the most recent change of -$501.57 million (-750.57%) on June 30, 2025.
- Over the past year, SMMT quarterly EBITDA has dropped by -$523.65 million (-1170.20%).
- SMMT quarterly EBITDA is now -1733.80% below its all-time high of $34.79 million, reached on July 31, 2018.
Performance
SMMT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$759.10M-$523.65M(-222.41%)Summary
- As of today (August 31, 2025), SMMT TTM EBITDA is -$759.10 million, with the most recent change of -$523.65 million (-222.41%) on June 30, 2025.
- Over the past year, SMMT TTM EBITDA has dropped by -$615.82 million (-429.81%).
- SMMT TTM EBITDA is now -23288.53% below its all-time high of -$3.25 million, reached on October 31, 2013.
Performance
SMMT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SMMT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -140.9% | -1170.2% | -429.8% |
| 3 y3 years | -101.7% | -3660.5% | -698.3% |
| 5 y5 years | -297.7% | -2948.9% | -2348.9% |
SMMT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -175.1% | at low | -4495.7% | at low | -1081.1% | at low |
| 5 y | 5-year | -297.7% | at low | -4495.7% | at low | -2348.9% | at low |
| alltime | all time | <-9999.0% | at low | -1733.8% | at low | <-9999.0% | at low |
SMMT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$568.40M(+750.6%) | -$759.10M(+222.4%) |
| Mar 2025 | - | -$66.83M(+1.6%) | -$235.45M(+11.5%) |
| Dec 2024 | -$211.22M(+140.9%) | -$65.78M(+13.2%) | -$211.20M(+16.5%) |
| Sep 2024 | - | -$58.09M(+29.8%) | -$181.21M(+26.5%) |
| Jun 2024 | - | -$44.75M(+5.1%) | -$143.28M(+25.9%) |
| Mar 2024 | - | -$42.58M(+18.9%) | -$113.82M(+29.8%) |
| Dec 2023 | -$87.69M(+14.2%) | -$35.80M(+77.6%) | -$87.70M(+36.5%) |
| Sep 2023 | - | -$20.16M(+31.8%) | -$64.27M(-2.3%) |
| Jun 2023 | - | -$15.30M(-7.0%) | -$65.80M(+0.3%) |
| Mar 2023 | - | -$16.45M(+33.0%) | -$65.62M(-13.1%) |
| Dec 2022 | -$76.79M(-26.7%) | -$12.37M(-43.0%) | -$75.52M(-18.9%) |
| Sep 2022 | - | -$21.69M(+43.5%) | -$93.12M(-2.1%) |
| Jun 2022 | - | -$15.12M(-42.6%) | -$95.09M(-12.9%) |
| Mar 2022 | - | -$26.35M(-12.1%) | -$109.16M(+4.3%) |
| Dec 2021 | -$104.70M(+50.3%) | -$29.96M(+26.6%) | -$104.70M(+16.3%) |
| Sep 2021 | - | -$23.66M(-18.9%) | -$90.00M(+4.3%) |
| Jun 2021 | - | -$29.18M(+33.4%) | -$86.26M(+13.9%) |
| Mar 2021 | - | -$21.89M(+43.4%) | -$75.72M(+14.4%) |
| Dec 2020 | -$69.64M(+31.1%) | - | - |
| Dec 2020 | - | -$15.26M(-23.4%) | -$66.19M(+30.0%) |
| Sep 2020 | - | -$19.93M(+6.9%) | -$50.93M(+64.3%) |
| Jun 2020 | - | -$18.64M(+50.9%) | -$31.00M(+150.9%) |
| Mar 2020 | - | -$12.35M(-18.2%) | -$12.35M(+34.5%) |
| Dec 2019 | -$53.11M(+55.1%) | - | - |
| Jan 2019 | - | -$15.10M(-1.5%) | -$9.19M(-5.6%) |
| Oct 2018 | - | -$15.33M(-144.1%) | -$9.73M(+198.8%) |
| Jul 2018 | - | $34.79M(-356.8%) | -$3.26M(-92.5%) |
| Apr 2018 | - | -$13.55M(-13.4%) | -$43.61M(+17.2%) |
| Jan 2018 | -$34.24M | - | - |
| Jan 2018 | - | -$15.64M(+76.6%) | -$37.19M(+27.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2017 | - | -$8.86M(+59.2%) | -$29.10M(+7.8%) |
| Jul 2017 | - | -$5.56M(-22.0%) | -$27.00M(-14.6%) |
| Apr 2017 | - | -$7.14M(-5.5%) | -$31.61M(-5.3%) |
| Jan 2017 | -$32.42M(-3.1%) | - | - |
| Jan 2017 | - | -$7.55M(+11.7%) | -$33.36M(-4.5%) |
| Oct 2016 | - | -$6.76M(-33.6%) | -$34.92M(-4.3%) |
| Jul 2016 | - | -$10.17M(+14.4%) | -$36.47M(+9.0%) |
| Apr 2016 | - | -$8.89M(-2.4%) | -$33.47M(+9.4%) |
| Jan 2016 | -$33.46M(+48.9%) | - | - |
| Jan 2016 | - | -$9.11M(+9.6%) | -$30.61M(+12.1%) |
| Oct 2015 | - | -$8.31M(+15.9%) | -$27.30M(+16.6%) |
| Jul 2015 | - | -$7.17M(+18.9%) | -$23.42M(+5.1%) |
| Apr 2015 | - | -$6.03M(+3.9%) | -$22.29M(+6.2%) |
| Jan 2015 | -$22.48M(+101.0%) | - | - |
| Jan 2015 | - | -$5.80M(+31.0%) | -$21.00M(+8.5%) |
| Oct 2014 | - | -$4.43M(-26.6%) | -$19.35M(+6.5%) |
| Jul 2014 | - | -$6.04M(+27.6%) | -$18.17M(+49.7%) |
| Apr 2014 | - | -$4.73M(+13.8%) | -$12.14M(+63.9%) |
| Jan 2014 | -$11.18M(+98.7%) | - | - |
| Jan 2014 | - | -$4.16M(+28.1%) | -$7.40M(+128.1%) |
| Oct 2013 | - | -$3.25M | -$3.25M |
| Jan 2013 | -$5.63M(+25.9%) | - | - |
| Jan 2012 | -$4.47M(-12.6%) | - | - |
| Jan 2011 | -$5.11M(-9.5%) | - | - |
| Jan 2010 | -$5.65M(-72.7%) | - | - |
| Jan 2009 | -$20.71M(-3.7%) | - | - |
| Jan 2008 | -$21.50M(+183.5%) | - | - |
| Jan 2007 | -$7.59M(+152.0%) | - | - |
| Jan 2006 | -$3.01M(+485.8%) | - | - |
| Jan 2005 | -$513.80K(+316.7%) | - | - |
| Jan 2004 | -$123.30K | - | - |
FAQ
- What is Summit Therapeutics Inc. annual EBITDA?
- What is the all time high annual EBITDA for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. annual EBITDA year-on-year change?
- What is Summit Therapeutics Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. quarterly EBITDA year-on-year change?
- What is Summit Therapeutics Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Summit Therapeutics Inc.?
- What is Summit Therapeutics Inc. TTM EBITDA year-on-year change?
What is Summit Therapeutics Inc. annual EBITDA?
The current annual EBITDA of SMMT is -$211.22M
What is the all time high annual EBITDA for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high annual EBITDA is -$123.30K
What is Summit Therapeutics Inc. annual EBITDA year-on-year change?
Over the past year, SMMT annual EBITDA has changed by -$123.53M (-140.88%)
What is Summit Therapeutics Inc. quarterly EBITDA?
The current quarterly EBITDA of SMMT is -$568.40M
What is the all time high quarterly EBITDA for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high quarterly EBITDA is $34.79M
What is Summit Therapeutics Inc. quarterly EBITDA year-on-year change?
Over the past year, SMMT quarterly EBITDA has changed by -$523.65M (-1170.20%)
What is Summit Therapeutics Inc. TTM EBITDA?
The current TTM EBITDA of SMMT is -$759.10M
What is the all time high TTM EBITDA for Summit Therapeutics Inc.?
Summit Therapeutics Inc. all-time high TTM EBITDA is -$3.25M
What is Summit Therapeutics Inc. TTM EBITDA year-on-year change?
Over the past year, SMMT TTM EBITDA has changed by -$615.82M (-429.81%)